Long-Term Outcomes in Patients with Advanced Urothelial Carcinoma (Uc) Who Received Avelumab First-Line (1L) Maintenance with or Without Second-Line (2L) Treatment: Exploratory Analyses from Javelin Bladder 100.

AuthID
 P-00X-EAF
10
Author(s)
Bellmunt, J
·
Duran, MAC
·
Sridhar, SS
·
Gurney, H
·
Costa, N
·
Di Pietro, A
·
Huang, B
·
Gupta, S
·
Grivas, P
Document Type
Abstract
Year published
2022
Published
in JOURNAL OF CLINICAL ONCOLOGY, ISSN: 0732-183X
Volume: 40, Issue: 16
Indexing
Wos®
Publication Identifiers
Wos: WOS:000863680301380
Source Identifiers
ISSN: 0732-183X
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

footer slogan

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service